Spring 2010: Biology Dept. features talk on targeting breast cancer cells with a liposome-based drug delivery system
by Kathleen McCoy |
Friday, Feb. 26, 3:30-4:45 p.m.
CPISB, Room 120
Ph.D. student Max Kullberg will present his thesis defense, titled: Targeting of Her-2 Overexpressing Breast Cancer Cells with Immunoliposomes.
The goal of the research is to develop a liposome-based drug delivery system which targets Her-2 overexpressing breast tumors with high specificity. Overexpression of the Her-2 receptor occurs in many cancers but is most prevalent in breast tumors, with 20-30 percent of all cases displaying overexpression of the receptor.
In addition, Her-2 overexpressing breast tumors are often aggressive and have a high probability of metastasizing. In the research reported here, a drug delivery system has been created that selectively targets Her-2 overexpressing mammary cells by combining three liposomal technologies. Kullberg's talk will cover the details of these technologies.
Parking on the UAA campus is free of charge on Fridays. Refreshments will be provided following the discussion. If you have questions, please contact Elizabeth Winfree at (907) 796-4780.